Martin Norin - Kancera AB Chief Officer
| KAN Stock | SEK 1.52 0.09 6.29% |
Insider
Martin Norin is Chief Officer of Kancera AB
| Age | 64 |
| Phone | 46 8 50 12 60 80 |
| Web | https://www.kancera.com |
Kancera AB Management Efficiency
The company has return on total asset (ROA) of (0.2736) % which means that it has lost $0.2736 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.4732) %, meaning that it generated substantial loss on money invested by shareholders. Kancera AB's management efficiency ratios could be used to measure how well Kancera AB manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 4 records | INSIDER Age | ||
| Prof MBA | Sprint Bioscience AB | 64 | |
| Mathias Skalmstad | Sprint Bioscience AB | N/A | |
| Eva Tornberg | Veg of Lund | 75 | |
| Fredrik Carling | Veg of Lund | 52 | |
Management Performance
| Return On Equity | -0.47 | |||
| Return On Asset | -0.27 |
Kancera AB Leadership Team
Elected by the shareholders, the Kancera AB's board of directors comprises two types of representatives: Kancera AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Kancera. The board's role is to monitor Kancera AB's management team and ensure that shareholders' interests are well served. Kancera AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Kancera AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Thomas Olin, CEO Director | ||
| Martin Norin, Chief Officer | ||
| Hans Richter, Chief Officer | ||
| Peter Selin, Exec Devel | ||
| Niclas Brynne, Head Devel | ||
| Torbjrn Lundstrm, Chief Officer |
Kancera Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Kancera AB a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.47 | |||
| Return On Asset | -0.27 | |||
| Operating Margin | (72.39) % | |||
| Current Valuation | 14.76 M | |||
| Shares Outstanding | 79.53 M | |||
| Shares Owned By Insiders | 13.72 % | |||
| Shares Owned By Institutions | 2.86 % | |||
| Price To Earning | (11.64) X | |||
| Price To Book | 1.44 X | |||
| Price To Sales | 168.19 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kancera AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Complementary Tools for Kancera Stock analysis
When running Kancera AB's price analysis, check to measure Kancera AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kancera AB is operating at the current time. Most of Kancera AB's value examination focuses on studying past and present price action to predict the probability of Kancera AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kancera AB's price. Additionally, you may evaluate how the addition of Kancera AB to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |